Analgesic Solutions Blog Understanding the Difference Between Risk-Based Monitoring and QDSS

With the rising costs of conducting effective clinical trials, many sponsors have begun implementing Risk-Based Monitoring (RBM) into their clinical trials. RBM is the process of ensuring the quality of clinical trials by identifying, assessing, monitoring, and mitigating the risk that could affect the data quality or the subject safety in a study. RBM aims to allocate resources based on risk and need, rather than distributing resources equally across all sites to maximize the coverage while controlling costs.